The endothelin receptor is a major determinant for the nonlinear tissue distribution of the endothelin antagonist BQ-123

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 2, 1996, Pages 607-613

  Shin, Ho Chul ^a   Kato, Yukio ^a   Shitara, Yoshihisa ^a   Yamada, Tadashi ^a   Nakamura, Tatsuji ^b   Hisaka, Akihiro ^b   Sugiyama, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b BANYU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BINDING; DRUG TISSUE DISTRIBUTION; DRUG TISSUE LEVEL; HEART; INTESTINE; INTRAVENOUS DRUG ADMINISTRATION; KINETICS; LUNG; MALE; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN;

ANIMALS; BINDING, COMPETITIVE; MALE; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ENDOTHELIN; TISSUE DISTRIBUTION;

EID: 0030427029     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. AHAI, H., HORI, S., ARAMORI, I., OHKUBO, H. AND NAKANISHI, S.: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348; 730-732, 1990.
2. A receptor antagonist (BQ-123) attenuates the development of hypoxic pulmonary hypertension in vivo. Am. Rev. Respir. Dis. 147: A493, 1993.
3. HORI, S., KOMATSU, Y., SHIGEMOTO, R., MIZUNO, N. AND NAKANISHI, S.: Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinology 130: 1885-1895, 1992.
4. A) antagonist isolated from Streptomyces misakiensis. Biochem. Biophys. Res. Commun. 178: 132-137, 1991.
5. A receptor. J. Cardiovasc. Pharmacol. 20: suppl 12, S11-S4, 1992a.
6. A receptor. Life Sci. 60: 247-255, 1992b.
7. B) receptors. Life Sci. 51: 47-52, 1992c.
8. A receptor subtype. Eur. J. Pharmacol. 274: 1-6, 1995.
9. INOUE, A., YANAGISAWA, M., KIMURA, S., KASUYA, Y., MIYAUCHI, T., GOTO, K. AND MASAKI, T.: The human endothelin family: Three structurally and pharmacologically distinct isopeptide predicted by three separate genes. Proc. Natl. Acad. Sci. USA 86: 2863-2867, 1989.
10. B receptor. Br. J. Pharmacol. 109: 486-490, 1993.
11. KENGATHARAN, M., BROWN, T. J., RAEBURN, D. AND ROACH, A. G.: Study of endothelin receptor subtypes mediating contraction of rat aorta and trachea using agonists and putative antagonists. Br. J. Pharmacol. 110: suppl., 44P, 1993.
12. KOSEKI, C., IMAI, M., HIRATA, Y., YANAGISAWA, M. AND MASAKI, T.: Autographic distribution in rat tissues of binding sites for endothelin: A neuropeptide? Am. J. Physiol. 256: R858-R866, 1989.
13. MARBACH, P., BRINER, M., LEMAIRE, A., SCHWEITER, A. AND TERASAKI, T.: From somatostatin to sandostatin: Pharmacodynamics and pharmacokinetics. Metabolism 41: 7-10, 1992.
14. MCMAHON, E. G., BROWN, M. A., BERTENSHAW, S. R. AND CARTER, J. S.: Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats. Am. J. Hypertension 6: 667-673, 1993.
15. MINO, N., KOBAYASHI, M., NAKAJIMA, A., AMANO, H., SHIMAMOTO, K., ISHIKAWA, K., WATANABE, K., NISHIKIBE, M., YANO, M. AND IKEMOTO, F.: Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats. Eur. J. Pharmacol. 221: 77-83, 1992.
16. NAKAMURA, T., HISAKA, A., SAWASAKI, Y., SUZUKI, Y., FUJINO, N., FUKAMI, T., ISHIKAWA, K., YANO, M. AND SUGIYAMA, Y.: Hepatic uptake mechanism of peptidic endothelin antagonists. Xenobiot. Metab. Dispos. 9: suppl., 322, 1994.
17. NISHIKIBE, M., TSUCHIDA, S., OKADA, M., FUKURODA, T., SHIMAMOTO, K., YANO, M., ISHIKAWA, K. AND IKEMOTO, F.: Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model. Life Sci. 52: 717-724, 1993.
18. A receptor antagonist, in spontaneously hypertensive rats treated with doca-salt. Eur. J. Pharmacol. 289: 339-342, 1994.
19. PARKER-ROTELHO, L. H., CADE, C., PHILLIPS, P. E. AND RUBANYI, G.: Tissue specificity of endothelin synthesis and binding. In Endothelin, ed. by G. M. Rubanyi, pp. 72-102, Oxford University Press, New York, 1992.
20. ROUBERT, P., GILLARD-ROUBERT, V., POURMARIN, L., CORNET, S., GUILMARD, C., PLAS, P., PIROTZKI, E., CHARBRIER, P. E. AND BRAQUET, P.: Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure. J. Pharmacol. Exp. Ther. 45: 182-188, 1994.
21. A endothelin receptor. Biochem. Biophys. Res. Commun. 200: 679-686, 1994.
22. SAKURAI, T., YANAGISAWA, M. AND MASAKI, T.: Molecular characterization of endothelin receptors. Trends Pharmacol. Sci. 13: 103-108, 1992.
23. SUGIYAMA, Y. AND HANANO, M.: Receptor-mediated transport of peptide hormones and its importance in the overall hormone disposition in the body. Pharm. Res. 6: 192-202, 1989.
24. SUGIYAMA Y. AND KATO, Y.: In vitro models of hepatic uptake: Methods to determine kinetic parameters for receptor-mediated hepatic uptake. In Peptide-Based Drug Design: Controlling Transport and Metabolism, ed. by M. D. Taylor and G. L Amidon, pp. 525-551, American Chemical Society Books Department, Washington, DC, 1995.
25. B receptor. Biochem. Biophys. Res. Commun. 184: 953-959, 1992.
26. TERASAKI, T., MIZUKUCHI, H., ITOHO, C., TAMAI, I., LEMAIRE, M. AND TSUJI, A.: Hepatic uptake of octreotide, a long-acting somatostatin analogue, via a bile acid transport system. Pharm. Res. 12: 11-16, 1995.
27. THAISRIVONGS, S., PALS, D. T., HARRIS, D. W., KATI, W. M. AND TURNER, S. R.: Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo. J. Med. Chem. 28: 2088-2093, 1986.
28. WOOD, S. M., KRAENZLIM, M. E., ADRIAN, T. E. AND BLOOM, S. R.: Treatment of patients with pancreatic endocrine tumors using a new long-acting somatostatin analogue. Symptomatic and peptide responses. Gut 26: 438-444, 1985.
29. YAMAOKA, K., TANIGAWARA, Y., NAKAGAWA, T. AND UNO, T.: A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharm. Dyn. 4: 879-885, 1981.
30. YANAGISAWA, M., KURIHARA, H., HIMURA, S., TOMOBE, Y. KOBAYASHI, M., MITSUI, Y., YAZAKI, Y., KOTO, K. AND MASAKI, T.: A novel potent vasocontrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
31. YANAGISAWA, M. AND MASAKI, T.: Molecular biology and biochemistry of the endothelins. Trends Pharmacol. Sci. 10: 374-378, 1989.
32. ZIEGLER, K., LINS, W. AND FRIMMER, M.: Hepatocellular transport of cyclosomatostatins: Evidence for a carrier system related to the multispecific bile acid transporter. Biochim. Biophys. Acta. 1061: 287-296, 1991.